| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/13/2001 | DE10010976A1 Engine oil degradation evaluation method provides correction of oil viscosity reference value when engine oil level is topped up with fresh oil |
| 09/13/2001 | DE10010558A1 Process for continuously and rapidly acquiring changes in concentration of radon gas dissolved in water comprises pumping new radon-free gas through a gas chamber surrounded by water, and continuously measuring |
| 09/13/2001 | DE10010140A1 Automatic system processing e.g. histological and cytological preparations, comprises slides with code identifying them and determining their handling and treatment |
| 09/13/2001 | DE10010081A1 Apparatus for an electro-physiological study of biological material comprises an array of measurement electrodes on the carrier and a counter electrode within the sample vessel |
| 09/13/2001 | DE10009969A1 Sensor element used for the quantitative determination of mercury, has gold layer applied in partial surfaces in the form of bridge switch on thin carrier membrane |
| 09/13/2001 | DE10009313A1 Process for measuring the oxygen concentration in industrial gases comprises measuring high gas contents using a high concentration analysis device and low gas contents using a low concentration analysis device |
| 09/13/2001 | DE10008969A1 Breathalyzer uses gallium oxide gas sensor mounted in housing with partition wall containing aperture so that breath flows through in main stream and is deflected to form a sub-stream which flows over sensor |
| 09/13/2001 | DE10008664A1 Concrete testing method and apparatus suitable for use with both low and high water content concrete for determining density, air content and, after hardening in the mold, tensile strength |
| 09/13/2001 | DE10008481A1 Bone cement consistency measuring device uses evaluation of impedance or conductivity of capacitive element using bone cement as dielectric |
| 09/13/2001 | DE10008402A1 Process for measuring the hydrogen concentration in a gas-vapor mixture in a nuclear facility comprises using signals produced from two sensors to evaluate the hydrogen concentration |
| 09/13/2001 | DE10008373A1 Determining activity of ligand-activatable ion channels comprises measuring resistance or conductivity of two cell samples in conductive liquid, where an active material, e.g. pharmaceutical or insecticide, is added to second sample |
| 09/13/2001 | CA2723031A1 Polypeptides having neutrophil stimulating activity |
| 09/13/2001 | CA2643537A1 Optical volume sensor |
| 09/13/2001 | CA2571917A1 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 09/13/2001 | CA2402606A1 Method for predicting protein-protein interactions |
| 09/13/2001 | CA2402602A1 Polynucleotides which are of nature b2/d+ a- and which are isolated from e. coli, and biological uses of these polynucleotides and of their polypeptides |
| 09/13/2001 | CA2402425A1 Health analysis and forecast of abnormal conditions |
| 09/13/2001 | CA2402412A1 Human extracellular signal regulated kinases |
| 09/13/2001 | CA2402371A1 Continuous analyzer of volatile organic compounds, device and method for continuously assessing the quality of inside ambient air and use of said device for monitoring a ventilation installation |
| 09/13/2001 | CA2402341A1 Metabotropic glutamate receptor antagonists for treating tolerance and dependency |
| 09/13/2001 | CA2402306A1 Method and system for the simultaneous and multiple detection and quantification of the hybridization of molecular compounds such as nucleic acids, dna, rna, pna and proteins |
| 09/13/2001 | CA2402239A1 A collection system for storage and manipulation of a sample |
| 09/13/2001 | CA2402214A1 T1r taste receptors and genes encoding same |
| 09/13/2001 | CA2402176A1 Method of monitoring hiv assembly and maturation |
| 09/13/2001 | CA2402157A1 Detection of chitin-containing contaminants such as microorganisms |
| 09/13/2001 | CA2402115A1 Medical diagnostic system |
| 09/13/2001 | CA2402111A1 Improved reverse n-hybrid screening method |
| 09/13/2001 | CA2402081A1 A compound that selectively binds to cd123 and use thereof to kill hematologic cancer progenitor cells |
| 09/13/2001 | CA2401964A1 New abc transporter atil |
| 09/13/2001 | CA2401946A1 Rfrp-containing prolactin secretion regulatory agent |
| 09/13/2001 | CA2401549A1 G-protein coupled receptor related polypeptides |
| 09/13/2001 | CA2401518A1 Device and method for performing syntheses, analyses or transport processes |
| 09/13/2001 | CA2401508A1 Electrical impedance measuring method for differentiating tissue types |
| 09/13/2001 | CA2401454A1 G-protein coupled receptors |
| 09/13/2001 | CA2401414A1 Materials with silicon-containing layers for use in miniaturized arrays and methods of manufacturing |
| 09/13/2001 | CA2401323A1 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 09/13/2001 | CA2401320A1 Random truncation and amplification of nucleic acid |
| 09/13/2001 | CA2400989A1 Function homology screening |
| 09/13/2001 | CA2400814A1 Microstamping activated polymer surfaces |
| 09/13/2001 | CA2400339A1 Method for analysing the length of a nucleic acid molecule |
| 09/13/2001 | CA2400065A1 Methods of diagnosing and monitoring endometrial glandular development |
| 09/13/2001 | CA2399943A1 Immune system-related polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | CA2399921A1 Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | CA2399913A1 Adam polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | CA2399202A1 Use of recombinant antigens to determine the immune status of an animal |
| 09/13/2001 | CA2399055A1 Synergistic activation of regulatory elements by rel proteins and a steroid receptor |
| 09/13/2001 | CA2398280A1 Epoxide polymer surfaces |
| 09/13/2001 | CA2373708A1 Phytomics: a genomic-based approach to herbal compositions |
| 09/13/2001 | CA2373705A1 Quantum dots, semiconductor nanocrystals and semiconductor particles used as fluorescent coding elements |
| 09/12/2001 | EP1132739A1 Linker system for activating surfaces for bioconjugation and methods for their use |
| 09/12/2001 | EP1132589A1 Catalyst state detector for exhaust gas purifying catalyst |
| 09/12/2001 | EP1132485A2 Method and device for detecting hybridization reaction |
| 09/12/2001 | EP1132483A2 Method for diagnosing schizophrenia using objective indices |
| 09/12/2001 | EP1132482A2 Method and reagent for determination of cholesterol in remnant-like lipoprotein particles |
| 09/12/2001 | EP1132471A2 TNF-binding proteins |
| 09/12/2001 | EP1132468A1 MAST CELL-SPECIFIC SIGNAL TRANSDUCING MOLECULES AND cDNAS THEREOF |
| 09/12/2001 | EP1132467A2 Novel creatine amidinohydrolase, production thereof and use thereof |
| 09/12/2001 | EP1132405A1 Novel g protein-coupled receptor protein, its dna and ligand thereof |
| 09/12/2001 | EP1132398A2 DNA sequence encoding the specific and antigenic outer membrane protein of salmonella typhi |
| 09/12/2001 | EP1132136A2 Microarray, method for producing the same, and method for correcting inter-pin spotting amount error of the same |
| 09/12/2001 | EP1132135A2 Individual closure and closure carrier for reaction wells, storage and dispensing device for individual closures |
| 09/12/2001 | EP1132092A1 Coupling factor 6 inhibitor and potentiator and use thereof |
| 09/12/2001 | EP1131637A1 A method of detecting the presence of an analyte in a biological sample |
| 09/12/2001 | EP1131636A1 Antibodies to peptides that target git receptors and related methods |
| 09/12/2001 | EP1131635A1 An immunoassay for the determination of transmissible spongiform encephalopathies in bovine |
| 09/12/2001 | EP1131634A2 Determining the mechanism of beta-amyloid peptide generation |
| 09/12/2001 | EP1131633A2 Hiv-specific t-cell induction |
| 09/12/2001 | EP1131632A2 Device and method for analyzing a biologic sample |
| 09/12/2001 | EP1131631A1 In situ method of analyzing cells |
| 09/12/2001 | EP1131629A1 Reagent composition and method for identification of reticulated cells |
| 09/12/2001 | EP1131628A1 Protein quantitation with cell imaging densitometry |
| 09/12/2001 | EP1131616A1 Methods of use for sensor based fluid detection devices |
| 09/12/2001 | EP1131615A1 Method and system for extracting, analysing and measuring constituents transported by a bore fluid |
| 09/12/2001 | EP1131471A2 A system for cell-based screening |
| 09/12/2001 | EP1131470A1 Cellular arrays and methods of detecting and using genetic disorder markers |
| 09/12/2001 | EP1131469A2 Visualization of rna in living cells |
| 09/12/2001 | EP1131468A2 Primer extension methods utilizing donor and acceptor molecules for detecting nucleic acids |
| 09/12/2001 | EP1131467A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 09/12/2001 | EP1131464A1 Method for screening for substances which are activators, inhibitors or binders of pkb by the use of a substrate peptide and the use of the substrate peptide |
| 09/12/2001 | EP1131463A1 Use of activated trap for screening for specific inhibitor of trap and method for aiding in the identification of a compound for use in the treatment of diseases or degenerative conditions resulting in increased bone resorption |
| 09/12/2001 | EP1131462A1 Analytical system based upon spore germination |
| 09/12/2001 | EP1131461A1 N-terminally truncated her-2/neu protein as a cancer prognostic indicator |
| 09/12/2001 | EP1131450A2 Chimeric promoters capable of mediating gene expression in plants upon pathogen infection and uses thereof |
| 09/12/2001 | EP1131449A1 Method for identifying inhibitors of ipc synthase |
| 09/12/2001 | EP1131443A2 Human hydrolase proteins |
| 09/12/2001 | EP1131440A2 Process for oxidising terpenes |
| 09/12/2001 | EP1131436A1 Urotensins ii of mammals and their uses |
| 09/12/2001 | EP1131433A1 Members of the capsaicin/vanilloid receptor family of proteins and uses thereof |
| 09/12/2001 | EP1131429A1 Calcium binding protein |
| 09/12/2001 | EP1131428A2 Immunoglobulin superfamily proteins |
| 09/12/2001 | EP1131426A2 Mage-10 or mage-8 derived hla-a2.1-binding oligopeptides |
| 09/12/2001 | EP1131425A2 Inflammation-associated genes |
| 09/12/2001 | EP1131424A2 Mutation of the parkin gene, compositions, methods and uses |
| 09/12/2001 | EP1131419A1 Methods for validating polypeptide targets that correlate to cellular phenotypes |
| 09/12/2001 | EP1131357A1 Humanized antibody specific for human 4-1bb and pharmaceutical composition comprising same |
| 09/12/2001 | EP1131356A1 Method for inhibiting macrophage infiltration using monoclonal anti-alpha-d-antibodies |
| 09/12/2001 | EP1131355A1 Method for producing antibodies acting against a polypeptide that only recognises the coding nucleic acid |
| 09/12/2001 | EP1131351A2 Peptides that modulate the interaction of b class ephrins and pdz domains |
| 09/12/2001 | EP1131350A1 Egf-like nucleic acids and polypeptides and uses thereof |
| 09/12/2001 | EP1131349A2 Potassium channel interactors and uses therefor |